Answer
Trifluridine/Tipiracil Servier is indicated as monotherapy for adults with metastatic gastric cancer, including adenocarcinoma of the gastroesophageal junction, previously treated with at least two systemic treatment regimens for advanced disease.
Sources for this answer
- Trifluridine/Tipiracil ServierServier Laboratories Limited · emc · SmPC §4.1 Therapeutic Indications · Version 12Document updated
Sources checked